Crescent Biopharma (CBIO) Receivables - Other (2013 - 2025)
Crescent Biopharma (CBIO) posted Receivables - Other of $78,762 for Q1 2025, down 28.4% from $109,946 a year earlier and down 42.3% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Receivables - Other (2013 - 2025) Analysis & Trends
At the end of FY2024, Crescent Biopharma's Receivables - Other came in at $136,580, down 22.3% from FY2023.
- Annual Receivables - Other shows a five-year compound annual growth rate of -6.0% (FY2019 to FY2024).
- In prior years, Crescent Biopharma's Receivables - Other was $175,820 in FY2023 (+22.1%), $144,016 in FY2022, $1,347 in FY2021 (-37.3%) and $2,149 in FY2020 (-98.8%).
- Quarterly Receivables - Other has run from a low of $1,347 in Q4 2021 to a high of $444,568 in Q1 2021 over five years.
- On a year-over-year basis, Receivables - Other has declined in each of the last five quarters, with an average decline of 4.0% over the last eight quarters.
- The strongest year-over-year quarter for Receivables - Other in the past five years was Q1 2021, with growth of 385.1%; the weakest was Q3 2020, with a decline of 99.7%.
- According to Business Quant data, Receivables - Other for the three prior quarters was $136,580 (Q4 2024), $50,255 (Q3 2024) and $76,710 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Crescent Biopharma | 403.30 Mn | -304.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 78,762.00 |
| Dec 31, 2024 | 136,580.00 |
| Sep 30, 2024 | 50,255.00 |
| Jun 30, 2024 | 76,710.00 |
| Mar 31, 2024 | 109,946.00 |
| Dec 31, 2023 | 175,820.00 |
| Sep 30, 2023 | 188,949.00 |
| Jun 30, 2023 | 215,368.00 |
| Mar 31, 2023 | 234,114.00 |
| Dec 31, 2022 | 144,016.00 |
| Sep 30, 2022 | 90,331.00 |
| Jun 30, 2022 | 120,866.00 |
| Mar 31, 2022 | 4,775.00 |
| Dec 31, 2021 | 1,347.00 |
| Sep 30, 2021 | 1,443.00 |
| Jun 30, 2021 | 1,656.00 |
| Mar 31, 2021 | 444,568.00 |
| Dec 31, 2020 | 2,149.00 |
| Sep 30, 2020 | 1,672.00 |
| Jun 30, 2020 | 49,362.00 |
API Access
Crescent Biopharma Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();